Use of Intranasal Naloxone by Basic Life Support Providers - PubMed (original) (raw)
Use of Intranasal Naloxone by Basic Life Support Providers
Scott G Weiner et al. Prehosp Emerg Care. 2017 May-Jun.
Abstract
Study objectives: Intranasal delivery of naloxone to reverse the effects of opioid overdose by Advanced Life Support (ALS) providers has been studied in several prehospital settings. In 2006, in response to the increase in opioid-related overdoses, a special waiver from the state allowed administration of intranasal naloxone by Basic Life Support (BLS) providers in our city. This study aimed to determine: 1) if patients who received a 2-mg dose of nasal naloxone administered by BLS required repeat dosing while in the emergency department (ED), and 2) the disposition of these patients.
Methods: This was a retrospective review of patients transported by an inner-city municipal ambulance service to one of three academic medical centers. We included patients aged 18 and older that were transported by ambulance between 1/1/2006 and 12/12/2012 and who received intranasal naloxone by BLS providers as per a state approved protocol. Site investigators matched EMS run data to patients from each hospital's EMR and performed a chart review to confirm that the patient was correctly identified and to record the outcomes of interest. Descriptive statistics were then generated.
Results: A total of 793 patients received nasal naloxone by BLS and were transported to three hospitals. ALS intervened and transported 116 (14.6%) patients, and 11 (1.4%) were intubated in the field. There were 724 (91.3%) patients successfully matched to an ED chart. Hospital A received 336 (46.4%) patients, Hospital B received 210 (29.0%) patients, and Hospital C received 178 (24.6%) patients. Mean age was 36.2 (SD 10.5) years and 522 (72.1%) were male; 702 (97.1%) were reported to have abused heroin while 21 (2.9%) used other opioids. Nasal naloxone had an effect per the prehospital record in 689 (95.2%) patients. An additional naloxone dose was given in the ED to 64 (8.8%) patients. ED dispositions were: 507 (70.0%) discharged, 105 (14.5%) admitted, and 112 (15.5%) other (e.g., left against medical advice, left without being seen, or transferred).
Conclusions: Only a small percentage of patients receiving prehospital administration of nasal naloxone by BLS providers required additional doses of naloxone in the ED and the majority of patients were discharged.
Keywords: basic life support; naloxone; opioid overdose.
Similar articles
- Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England.
Gulec N, Lahey J, Suozzi JC, Sholl M, MacLean CD, Wolfson DL. Gulec N, et al. Prehosp Emerg Care. 2018 Mar-Apr;22(2):163-169. doi: 10.1080/10903127.2017.1371262. Epub 2017 Oct 12. Prehosp Emerg Care. 2018. PMID: 29023172 - A Comparison of Efficacy of Treatment and Time to Administration of Naloxone by BLS and ALS Providers.
Nugent K, Matthews P, Gissendaner J, Papas M, Occident D, Patel A, Johnson M, Megargel RE, Nomura JT. Nugent K, et al. Prehosp Disaster Med. 2019 Aug;34(4):350-355. doi: 10.1017/S1049023X19004527. Epub 2019 Jul 19. Prehosp Disaster Med. 2019. PMID: 31322097 - Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.
Klebacher R, Harris MI, Ariyaprakai N, Tagore A, Robbins V, Dudley LS, Bauter R, Koneru S, Hill RD, Wasserman E, Shanes A, Merlin MA. Klebacher R, et al. Prehosp Emerg Care. 2017 Nov-Dec;21(6):682-687. doi: 10.1080/10903127.2017.1335818. Epub 2017 Jul 7. Prehosp Emerg Care. 2017. PMID: 28686547 - Do heroin overdose patients require observation after receiving naloxone?
Willman MW, Liss DB, Schwarz ES, Mullins ME. Willman MW, et al. Clin Toxicol (Phila). 2017 Feb;55(2):81-87. doi: 10.1080/15563650.2016.1253846. Epub 2016 Nov 16. Clin Toxicol (Phila). 2017. PMID: 27849133 Review. - Emergency medical services naloxone access: a national systematic legal review.
Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW. Davis CS, et al. Acad Emerg Med. 2014 Oct;21(10):1173-7. doi: 10.1111/acem.12485. Acad Emerg Med. 2014. PMID: 25308142 Review.
Cited by
- One year mortality of patients treated with naloxone for opioid overdose by emergency medical services.
Weiner SG , MD, MPH, Baker O , PhD, Bernson D , MPH, Schuur JD , MD, MS. Weiner SG , MD, MPH, et al. Subst Abus. 2022;43(1):99-103. doi: 10.1080/08897077.2020.1748163. Epub 2020 Apr 3. Subst Abus. 2022. PMID: 32242763 Free PMC article. - Defining the Correlation Between Heroin Overdose and Length of Hospital Admissions.
Reinert J, Leis R, Paplaskas A, Bakle-Carn D. Reinert J, et al. J Pharm Technol. 2019 Dec;35(6):243-250. doi: 10.1177/8755122519860081. Epub 2019 Jun 28. J Pharm Technol. 2019. PMID: 34752513 Free PMC article. - Variations in the California Emergency Medical Services Response to Opioid Use Disorder.
Glober NK, Hern G, McBride O, Mercer MP. Glober NK, et al. West J Emerg Med. 2020 Apr 16;21(3):671-676. doi: 10.5811/westjem.2019.12.45189. West J Emerg Med. 2020. PMID: 32421518 Free PMC article. - Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine.
Strang J, McDonald R, Campbell G, Degenhardt L, Nielsen S, Ritter A, Dale O. Strang J, et al. Drugs. 2019 Sep;79(13):1395-1418. doi: 10.1007/s40265-019-01154-5. Drugs. 2019. PMID: 31352603 Free PMC article. Review. - Evaluation of Basic Life Support First Responder Naloxone Administration Protocol Adherence.
Mastenbrook J, Emrick D, Bauler LD, Markman J, Koedam T, Fales W. Mastenbrook J, et al. Cureus. 2021 Oct 20;13(10):e18932. doi: 10.7759/cureus.18932. eCollection 2021 Oct. Cureus. 2021. PMID: 34812316 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous